BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9244654)

  • 1. [40 years breast carcinoma treatment in the Neubrandenburg region.Can an increase in prognostically more favorable stages be detected?].
    Rühle H; Grobe N; Balschat S; Ernst KF; Dewitz D; Winkler L
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):135-7. PubMed ID: 9244654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breast cancer screening. State of the art and introduction to preventive measures].
    von Fournier D; Anton HW; Junkermann H; Bastert G; van Kaick G
    Radiologe; 1993 May; 33(5):227-35. PubMed ID: 8516433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years.
    Maibenco D; Daoud Y; Phillips E; Saxe A
    Am Surg; 1999 Nov; 65(11):1061-6. PubMed ID: 10551757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in TNM stages in breast carcinoma over the course of 20 years].
    Höfig G; Dettbarn M; Fritzsche A; Hohaus B
    Zentralbl Chir; 1998; 123 Suppl 5():23-4. PubMed ID: 10063566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
    Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
    Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
    Singh R; Hellman S; Heimann R
    Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for breast cancer.
    Duffy SW; Smith RA; Gabe R; Tabár L; Yen AM; Chen TH
    Surg Oncol Clin N Am; 2005 Oct; 14(4):671-97. PubMed ID: 16226686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?
    Jensen AR; Garne JP; Storm HH; Engholm G; Möller T; Overgaard J
    Acta Oncol; 2004; 43(8):719-26. PubMed ID: 15764216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening lowers breast cancer mortality. Motivate your patients for mammography].
    Kessler M; Schneider P; Sittek H; Reiser M
    MMW Fortschr Med; 2001 Jul; 143(28-29):32-5. PubMed ID: 11499144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of the localization technique of occult breast changes with reference to future screening programs].
    Hess T; Benz J; Juchler A
    Helv Chir Acta; 1992 May; 59(1):263-8. PubMed ID: 1526839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Service screening mammography reduces breast cancer mortality among elderly women in Turku.
    Parvinen I; Helenius H; Pylkkänen L; Anttila A; Immonen-Räihä P; Kauhava L; Räsänen O; Klemi PJ
    J Med Screen; 2006; 13(1):34-40. PubMed ID: 16569304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
    Wärnberg F; Bergh J; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
    Jensen AR; Madsen AH; Overgaard J
    Acta Oncol; 2008; 47(4):537-44. PubMed ID: 18465319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey.
    Sabatino SA; Burns RB; Davis RB; Phillips RS; Chen YH; McCarthy EP
    Cancer; 2004 Jun; 100(11):2338-46. PubMed ID: 15160336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of magnetic resonance imaging in breast cancer screening.
    Lee CH; Weinreb JC
    J Am Coll Radiol; 2004 Mar; 1(3):176-82. PubMed ID: 17411555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.